Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.78
-0.17-5.76%
Last update: Nov 13, 9:56 AM
Comments
Loading...
Gain Therapeutics (GANX) Stock Price, Quote, News & History
GANXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gain Therapeutics (GANX) stock?
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Who are Gain Therapeutics (GANX) competitors?
Other companies in Gain Therapeutics’s space includes: InflaRx (NASDAQ:IFRX), Adverum Biotechnologies (NASDAQ:ADVM), Zentalis Pharma (NASDAQ:ZNTL), Atossa Therapeutics (NASDAQ:ATOS) and Citius Oncology (NASDAQ:CTOR).
What is the forecast, or price target, for Gain Therapeutics (GANX) stock?
Gain Therapeutics has a consensus price target of $8.00.
What is the current price for Gain Therapeutics (GANX)?
The stock price for Gain Therapeutics (NASDAQ: GANX) is $2.78 last updated November 13, 2025 at 9:56 AM EST.
Does Gain Therapeutics (GANX) pay a dividend?
There are no upcoming dividends for Gain Therapeutics.
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics’s Q3 earnings are confirmed for Wednesday, November 12, 2025.
Is Gain Therapeutics (GANX) going to split?
There is no upcoming split for Gain Therapeutics.
What sector and industry does Gain Therapeutics (GANX) operate in?
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
